Korean Regulatory Post Marketing Surveillance for Somavert — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Korean Regulatory Post Marketing Surveillance for Somavert — Stella

Home/Acromegaly/

View on ClinicalTrials.gov

Recruiting

Back to Acromegaly trials

Trial locations(1 site)

South Korea

Pfizer, Seoul

Key details

Sponsor

Pfizer

Enrollment target

~100 participants

Started

July 2022

Primary completion

September 2026

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.